Literature DB >> 23914148

2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy.

Michael N Neuss1, Martha Polovich, Kristen McNiff, Peg Esper, Terry R Gilmore, Kristine B LeFebvre, Lisa Schulmeister, Joseph O Jacobson.   

Abstract

In 2009, ASCO and the Oncology Nursing Society (ONS) published standards for the safe use of parenteral chemotherapy in the outpatient setting, including issues of practitioner orders, preparation, and administration of medication. In 2011, these were updated to include inpatient facilities. In December 2011, a multistakeholder workgroup met to address the issues associated with orally administered antineoplastics, under the leadership of ASCO and ONS. The workgroup participants developed recommended standards, which were presented for public comment. Public comments informed final edits, and the final standards were reviewed and approved by the ASCO and ONS Boards of Directors. Significant newly identified recommendations include those associated with drug prescription and the necessity of ascertaining that prescriptions are filled. In addition, the importance of patient and family education regarding administration schedules, exception procedures, disposal of unused oral medication, and aspects of continuity of care across settings were identified. This article presents the newly developed standards.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23914148      PMCID: PMC3731124          DOI: 10.1200/JOP.2013.000874

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  15 in total

Review 1.  NCCN Task Force Report: Oral chemotherapy.

Authors:  Saul N Weingart; Elizabeth Brown; Peter B Bach; Kirby Eng; Shirley A Johnson; Timothy M Kuzel; Terry S Langbaum; R Donald Leedy; Raymond J Muller; Lee N Newcomer; Susan O'Brien; Denise Reinke; Mark Rubino; Leonard Saltz; Ronald S Walters
Journal:  J Natl Compr Canc Netw       Date:  2008-03       Impact factor: 11.908

2.  Quality oncology practice initiative certification program: overview, measure scoring methodology, and site assessment standards.

Authors:  Kristen K McNiff; Katherine R Bonelli; Joseph O Jacobson
Journal:  J Oncol Pract       Date:  2009-11       Impact factor: 3.840

3.  Medication errors involving oral chemotherapy.

Authors:  Saul N Weingart; Julio Toro; Justin Spencer; Deborah Duncombe; Anne Gross; Sylvia Bartel; Jeremy Miransky; Ann Partridge; Lawrence N Shulman; Maureen Connor
Journal:  Cancer       Date:  2010-05-15       Impact factor: 6.860

4.  Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer.

Authors:  Alfred I Neugut; Milayna Subar; Elizabeth Ty Wilde; Scott Stratton; Corey H Brouse; Grace Clarke Hillyer; Victor R Grann; Dawn L Hershman
Journal:  J Clin Oncol       Date:  2011-05-23       Impact factor: 44.544

Review 5.  Adherence to oral chemotherapy in childhood acute lymphoblastic leukemia: an evolutionary concept analysis.

Authors:  Wendy Landier
Journal:  Oncol Nurs Forum       Date:  2011-05       Impact factor: 2.172

6.  Revisions to the 2009 american society of clinical oncology/oncology nursing society chemotherapy administration safety standards: expanding the scope to include inpatient settings.

Authors:  Joseph O Jacobson; Martha Polovich; Terry R Gilmore; Lisa Schulmeister; Peg Esper; Kristine B Lefebvre; Michael N Neuss
Journal:  J Oncol Pract       Date:  2011-12-13       Impact factor: 3.840

7.  Patient preferences for oral versus intravenous palliative chemotherapy.

Authors:  G Liu; E Franssen; M I Fitch; E Warner
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

Review 8.  Patient adherence and persistence with oral anticancer treatment.

Authors:  Kathryn Ruddy; Erica Mayer; Ann Partridge
Journal:  CA Cancer J Clin       Date:  2009 Jan-Feb       Impact factor: 508.702

Review 9.  A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents.

Authors:  Cindi Holt Bedell
Journal:  Clin J Oncol Nurs       Date:  2003 Nov-Dec       Impact factor: 1.027

Review 10.  Patient education: the cornerstone of successful oral chemotherapy treatment.

Authors:  Kristine Hartigan
Journal:  Clin J Oncol Nurs       Date:  2003 Nov-Dec       Impact factor: 1.027

View more
  35 in total

1.  Time to get serious about improving the safety of oral chemotherapy.

Authors:  Monika K Krzyzanowska
Journal:  J Oncol Pract       Date:  2013-03       Impact factor: 3.840

2.  Analyzing temozolomide medication errors: potentially fatal.

Authors:  Nathalie Letarte; Michael P Gabay; Linda R Bressler; Katie E Long; Joan M Stachnik; J Lee Villano
Journal:  J Neurooncol       Date:  2014-07-16       Impact factor: 4.130

3.  Depressive symptoms predict cancer caregivers' physical health decline.

Authors:  Kelly M Shaffer; Youngmee Kim; Charles S Carver; Rachel S Cannady
Journal:  Cancer       Date:  2017-06-29       Impact factor: 6.860

4.  Multidisciplinary Optimization of Oral Chemotherapy Delivery at the University of Wisconsin Carbone Cancer Center.

Authors:  Daniel L Mulkerin; Jason J Bergsbaken; Jessica A Fischer; Mary J Mulkerin; Aaron M Bohler; Mary S Mably
Journal:  J Oncol Pract       Date:  2016-10       Impact factor: 3.840

5.  Recommendations for the safe use and handling of oral anticancer drugs in community pharmacy: A pan-Canadian consensus guideline.

Authors:  Kathy Vu; Philip Emberley; Erika Brown; Rick Abbott; Justin J Bates; Venetia Bourrier; Kathryn Djordjevic; Julie Greenall; Mova Leung; Mark Pasetka; Louise Paquet; Heather Logan
Journal:  Can Pharm J (Ott)       Date:  2018-05-16

6.  Hazardous Drugs: Legislative and Regulatory Efforts to Improve Safe Handling

Authors:  AnnMarie L Walton; Seth Eisenberg; Christopher R Friese
Journal:  Clin J Oncol Nurs       Date:  2017-04-01       Impact factor: 1.027

7.  New Oral Anti-Cancer Drugs and Medication Safety.

Authors:  Katja Schlichtig; Pauline Dürr; Frank Dörje; Martin F Fromm
Journal:  Dtsch Arztebl Int       Date:  2019-11-15       Impact factor: 5.594

Review 8.  A Systematic Review of Adherence to Oral Antineoplastic Therapies.

Authors:  Joseph A Greer; Nicole Amoyal; Lauren Nisotel; Joel N Fishbein; James MacDonald; Jamie Stagl; Inga Lennes; Jennifer S Temel; Steven A Safren; William F Pirl
Journal:  Oncologist       Date:  2016-02-26

Review 9.  Oral antineoplastic agents: how do we care about adherence?

Authors:  Marie Barillet; Virginie Prevost; Florence Joly; Bénédicte Clarisse
Journal:  Br J Clin Pharmacol       Date:  2015-10-28       Impact factor: 4.335

10.  Improving the Safety of Oral Chemotherapy at an Academic Medical Center.

Authors:  Nirav N Shah; Erica Casella; Donna Capozzi; Suzanne McGettigan; Tara C Gangadhar; Lynn Schuchter; Jennifer S Myers
Journal:  J Oncol Pract       Date:  2016-01-05       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.